Abstract | BACKGROUND: METHODS: The study included 1015 patients, ages 14-82 (mean age 42.21 ± 10.8), admitted to Acibadem Breast Clinic between January 2015 and March 2018. The patients were divided into group I (n = 581) treated with EPO (1300 mg, twice a day) and group II (n = 434) treated with paracetamol (500 mg, twice a day). The visual analog scale was used to assess EPO's therapeutic efficacy, compared with paracetamol, measured at admittance, 2 weeks, and 6 weeks. Clinical factors affecting the efficacy of EPO were analyzed. RESULTS: CONCLUSION:
|
Authors | Fatih Levent Balci, Cihan Uras, Sheldon Feldman |
Journal | Annals of surgical oncology
(Ann Surg Oncol)
Vol. 27
Issue 12
Pg. 4844-4852
(Nov 2020)
ISSN: 1534-4681 [Electronic] United States |
PMID | 32748152
(Publication Type: Journal Article)
|
Chemical References |
- Linoleic Acids
- Plant Oils
- evening primrose oil
- gamma-Linolenic Acid
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Humans
- Linoleic Acids
- Mastodynia
(drug therapy, etiology)
- Middle Aged
- Oenothera biennis
- Plant Oils
- Young Adult
- gamma-Linolenic Acid
(therapeutic use)
|